文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人源抗体可延缓红细胞入侵，增强疟疾中和抗体。

Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.

机构信息

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK; Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.

出版信息

Cell. 2019 Jun 27;178(1):216-228.e21. doi: 10.1016/j.cell.2019.05.025. Epub 2019 Jun 13.

DOI:10.1016/j.cell.2019.05.025
PMID:31204103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6602525/
Abstract

The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the leading target for next-generation vaccines against the disease-causing blood-stage of malaria. However, little is known about how human antibodies confer functional immunity against this antigen. We isolated a panel of human monoclonal antibodies (mAbs) against PfRH5 from peripheral blood B cells from vaccinees in the first clinical trial of a PfRH5-based vaccine. We identified a subset of mAbs with neutralizing activity that bind to three distinct sites and another subset of mAbs that are non-functional, or even antagonistic to neutralizing antibodies. We also identify the epitope of a novel group of non-neutralizing antibodies that significantly reduce the speed of red blood cell invasion by the merozoite, thereby potentiating the effect of all neutralizing PfRH5 antibodies as well as synergizing with antibodies targeting other malaria invasion proteins. Our results provide a roadmap for structure-guided vaccine development to maximize antibody efficacy against blood-stage malaria.

摘要

疟原虫红细胞结合蛋白同源物 5（PfRH5）是针对疟疾致病血期的下一代疫苗的主要靶标。然而，人们对人类抗体如何赋予针对该抗原的功能免疫知之甚少。我们从基于 PfRH5 的疫苗首次临床试验中的疫苗接种者的外周血 B 细胞中分离出了一组针对 PfRH5 的人源单克隆抗体（mAbs）。我们鉴定出了一组具有中和活性的 mAbs，它们结合到三个不同的位点，还有一组 mAbs 没有功能，甚至对抗中和抗体具有拮抗作用。我们还确定了一组新型非中和抗体的表位，这些抗体显著降低了疟原虫裂殖子入侵红细胞的速度，从而增强了所有中和 PfRH5 抗体的效果，并与针对其他疟疾入侵蛋白的抗体协同作用。我们的研究结果为基于结构的疫苗开发提供了路线图，以最大限度地提高针对血期疟疾的抗体疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/c8da722049f4/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/57086aab4175/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/709557d39b48/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/fe7a6fc40911/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/7ecdedcf62b5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/6057a507286c/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/a5d189c8be99/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/fdb0a1a52386/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/66b02673ecb6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/41f75f1abaed/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/d0a4545078d9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/ad853fc76877/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/63f48a5dc588/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/085059de0c5c/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/59a04c4ab230/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/c8da722049f4/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/57086aab4175/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/709557d39b48/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/fe7a6fc40911/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/7ecdedcf62b5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/6057a507286c/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/a5d189c8be99/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/fdb0a1a52386/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/66b02673ecb6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/41f75f1abaed/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/d0a4545078d9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/ad853fc76877/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/63f48a5dc588/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/085059de0c5c/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/59a04c4ab230/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5857/6602525/c8da722049f4/figs7.jpg

相似文献

[1]
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.

Cell. 2019-6-13

[2]
Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.

J Immunol. 2013-11-29

[3]
A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.

Malar J. 2014-8-18

[4]
Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen.

Sci Rep. 2022-2-23

[5]
Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.

Infect Immun. 2013-10-14

[6]
Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against CyRPA.

Front Immunol. 2021

[7]
Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.

PLoS Pathog. 2012-11-8

[8]
APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces -Specific Neutralizing Antibodies and T Cell Responses.

Front Immunol. 2021-10-18

[9]
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.

Cell. 2024-9-5

[10]
Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5.

EMBO Mol Med. 2024-10

引用本文的文献

[1]
Advancing Food Safety Surveillance: Rapid and Sensitive Biosensing Technologies for Foodborne Pathogenic Bacteria.

Foods. 2025-7-29

[2]
CD44 cross-linking promotes invasion.

bioRxiv. 2025-7-30

[3]
Emerging Molecular Mechanisms in Malaria Pathogenesis and Novel Therapeutic Approaches: A Focus on Malaria.

Biomolecules. 2025-7-17

[4]
Deposition of complement regulators on the surface of Plasmodium falciparum merozoites depends on the immune status of the host.

PLoS Pathog. 2025-4-28

[5]
PfRH5 vaccine; from the bench to the vial.

NPJ Vaccines. 2025-4-24

[6]
A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade.

Cell Rep Med. 2025-3-18

[7]
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.

Immunol Rev. 2025-3

[8]
Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the population of Papua New Guinea.

Front Parasitol. 2023-12-22

[9]
Estimation of PfRh5-based vaccine efficacy in asymptomatic patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening.

Front Immunol. 2024-11-18

[10]
RH5 antigenic landscape shapes vaccine and antibody development.

Trends Pharmacol Sci. 2024-12

本文引用的文献

[1]
A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates.

Nat Commun. 2019-4-26

[2]
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.

Cell Rep. 2019-4-2

[3]
Production, quality control, stability, and potency of cGMP-produced RH5.1 protein vaccine expressed in S2 cells.

NPJ Vaccines. 2018-8-17

[4]
Malaria Vaccines: Recent Advances and New Horizons.

Cell Host Microbe. 2018-7-11

[5]
Liver Stage Infection and Transition to Stable Blood Stage Infection in Liver-Humanized and Blood-Humanized FRGN KO Mice Enables Testing of Blood Stage Inhibitory Antibodies (Reticulocyte-Binding Protein Homolog 5) .

Front Immunol. 2018-3-14

[6]
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

JCI Insight. 2017-11-2

[7]
Synergistic malaria vaccine combinations identified by systematic antigen screening.

Proc Natl Acad Sci U S A. 2017-10-23

[8]
The Molecular Basis of Erythrocyte Invasion by Malaria Parasites.

Cell Host Microbe. 2017-8-9

[9]
Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope.

J Virol. 2017-9-27

[10]
Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus.

Cell Rep. 2017-4-11

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索